Page last updated: 2024-11-08

1-(chloromethyl)silatrane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Silimin: contains collagen, hydroxyapatite & CM-silitrane; Russian compound; a biogenic composite material for dental implants [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID362521
CHEMBL ID2000017
SCHEMBL ID8418895
MeSH IDM0104675

Synonyms (33)

Synonym
42003-39-4
AKOS005429972
nsc626545
nsc-626545
chloromethylsilatrane
2,8,9-trioxa-5-aza-1-silabicyclo[3.3.3]undecane, 1-(chloromethyl)-
5-(chloromethyl)-4,6,11-trioxa-1-aza-5-silabicyclo[3.3.3]undecane
1-(chloromethyl)-2,8,9-trioxa-5-aza-1-silabicyclo[3.3.3]undecane
NCI60_008397
1-chloromethyl-2,8,9-trioxa-5-aza-1-sila-bicyclo[3.3.3]undecane
STK363119
2,8,9-trioxa-5-aza-1-silabicyclo(3.3.3)undecane, 1-(chloromethyl)-
silimin
1-(chloromethyl)silatrane
mival
1-(chloromethyl)-2,8,9-trioxa-5-aza-1-silabicyclo(3.3.3)undecane
1-chloromethylsilatrane
einecs 255-621-1
BBL000525
unii-7r9b5a0vph
7r9b5a0vph ,
1-(chloromethyl)-2,8,9-trioxa-5-aza-1- silabicyclo(3.3.3)undecane
1-chloromethyl silatrane
chloromethylsilatrane [who-dd]
2,8,9-trioxa-5-aza-1-silabicyclo(3.3.3)undecane, 1- (chloromethyl)-
CHEMBL2000017
SCHEMBL8418895
DTXSID2041383
mfcd00053377
1-chloromethyl-2,8,9-trioxa-5-aza-1-sila-bicyclo(3.3.3)undecane
VS-00636
Q27268749
CS-0357933
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (46.67)18.7374
1990's7 (46.67)18.2507
2000's1 (6.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.03

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.03 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index4.17 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.03)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (4.76%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (95.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]